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Abstract Calcific tendinitis is a painful shoulder disorder
characterised by either single or multiple deposits in the
rotator cuff tendon. Although the disease subsides sponta-
neously in most cases, a subpopulation of patients continue
to complain of pain and shoulder dysfunction and the
deposits do not show any signs of resolution. Although
several treatment options have been proposed, clinical
results are controversial and often the indication for a given
therapy remains a matter of clinician choice. Herein, we
report on the current state of the art in the pathogenesis,
diagnosis and treatment of calcific tendinitis of the rotator
cuff.
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Introduction
Calcific tendinitis (CT) is a painful shoulder disorder
characterised by either single or multiple deposits in the
rotator cuff (RC) tendon or subacromial bursa [1]. It was
Codman who, in his book [2], described the deposits as
being in the RC tendon. The term ‘‘calcifying tendinitis’’
was probably first coined by Plenk [3] in 1952. The disease
subsides spontaneously in the majority of cases and can be
managed with conservative therapy, but some patients
continue to have a painful shoulder for an extended period
of time with the deposits not showing any signs of reso-
lution. New conservative treatment modalities such as
ultrasound-guided needling (UGN) and extracorporeal
shock wave therapy (ESWT) have emerged in recent years
as additional management options. Incidence varies from
2.7 to 20 %, as reported by various authors [1, 4, 5]. In
about 10–20 % of patients, the deposits are bilateral [1, 5,
6]. Most studies found higher incidence in women com-
pared with men [1, 6]. Regarding age distribution, the
average age of presentation in most studies was between 30
and 50 years [5, 6]. No deposits were found in the elderly
[5, 7, 8]. Most investigators found the deposits to be more
commonly located in the supraspinatus [1, 3, 4, 6],
although often the deposits were also located in the
infraspinatus [1, 4, 6] and rarely in the subscapularis and
teres minor [1, 4]. Most patients were sedentary workers or
housewives [6]. The right shoulder was most commonly
affected [6]. The natural history of the disease can be
divided into three distinct clinical stages: acute, subacute
and chronic. The main clinical manifestation is pain, which
may or may not be associated with acute or gradual
restriction of movements [4, 9]. Acute pain is often asso-
ciated with the onset of the disease; however, the deposits
may be asymptomatic in 20 % of cases [6]. Muscle spasm,
and inflammation of subacromial bursa (bursitis) and the
long head of the biceps are determining symptomatic fac-
tors. The pain is, in most cases, associated with the acute
phase of the disease, but episodes of acute pain are also
often related to flare-ups of chronic tendinopathy or onset
of rare complications not related to the evolution of the
disease, such as adhesive capsulitis (AC), rotator cuff tear,
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pathology of the long head of the biceps or osteolysis of the
greater tuberosity (TO) [10, 11].
Aetiopathogenesis and histopathology
The aetiopathogenesis of CT remains elusive. Codman [2]
hypothesised that overuse degeneration of rotator cuff
leads to calcific deposits in the tendon, and this was also
supported by Bishop [12], whereas Sandstrom [13] pro-
posed that the degeneration in the tendon follows local
ischaemia which led to calcium deposition. More recently,
Mohr and Bilger [14] considered that the process begins
with necrosis of tenocytes due to apoptosis along with
intracellular accumulation of calcium, but a more detailed
description was given by Uhthoff et al. [15], who proposed
that the disease goes through three stages: precalcific,
calcific and postcalcific. In the precalcific stage, there is
fibrocartilaginous metaplasia in the tendon; this stage is
rarely symptomatic. This is followed by the calcific stage,
which is further divided into formative, resting and reab-
sorption phases. It is in the reabsorptive phase that patients
are mostly symptomatic. The postcalcific phase is the
healing phase, in which there is reabsorption of the deposit.
Rui et al. [16] postulated that incorrect differentiation of
stem cells, tendon-derived stem cells (TDSCs), into
osteoblasts or chondrocytes could be the basis of the cal-
cification. Disorders of the thyroid (thyroxine) or oestrogen
metabolism may be related to the onset of the disease.
Harvie et al. [17] reported endocrine involvement in
64.7 % of cases in their series, whereas Mavrikakis et al.
[18] reported CT incidence in 31.8 % of their diabetic
patients, compared with 10.3 % of the control group.
Sengar et al. [19] found an increased frequency of human
leucocyte antigen serotype class A1 in patients with CT.
Mutation in the human homologue of the murine progres-
sive ankylosis gene (ANKH) has been reported in patients
with hereditary chondrocalcinosis, leading to alteration of
the picture of extracellular inorganic pyrophosphate [20].
Oliva et al. [21] found that significantly increased expres-
sion of tissue transglutaminase (tTG)2 and its substrate
osteopontin was detected in calcific areas compared with
levels observed in normal tissue from the same subject with
calcific tendinopathy. They concluded that a variation in
the expression of these genes could be characteristic of this
form of tendinopathy. The correlation between increased
incidence of endocrine disorders and risk of developing CT
remains unclear; similarly, the associations with genetic
mutations, specific antigen serotypes and expression of
tissue proteins need to be understood more deeply. One
may speculate that patients with the aforementioned pre-
disposing conditions may be at greater risk of developing
CT. Furthermore, in this subpopulation of subjects,
abnormal pre-existing calcifications can produce or
enhance a complete RC tear, requiring a surgical approach.
Imaging
Conventional radiology
Standard radiographs in anterior–posterior (AP), outlet and
axillary views are used for diagnosis and follow-up of CT,
because they allow localisation and assessment of the
texture and morphology of the deposits [22, 23] (Fig. 1).
Many authors have tried to classify the deposits in terms of
size [1] or morphology [6, 24–26] (Table 1). However, the
fact that there are numerous classifications indicates that no
classification perfectly correlates with the radiological
picture and symptomatology of the patient, and there is
also significant inter-observer variability [27].
The location of the deposits in the tendons also varies [1,
22] (Table 2).
Ultrasound
Ultrasound (US) examination is a fundamental tool in
diagnosis and treatment of CT [28, 29]. US has changed
from having a purely diagnostic role to become an impor-
tant therapeutic tool, especially for carrying out bursal
lavage and tendon needling (Fig. 1b, c). Use of high-reso-
lution US shows the presence of deposits and also defines
their locations in the tendon, plus their size and texture. This
technique shows RC tears in detail, and also enables staging
of the deposits by correlation of shadow cones [30, 31]. In
the resting phase, the deposits appear hyperechoic and arc
shaped, whereas they appear non-arc shaped (fragmented/
punctate, cystic, nodular) in the resolving phase [30]. These
appearances can also be correlated with the symptomatic
and asymptomatic phases of the disease [32]. Farin et al.
[33] divided the deposits into three types: (1) hyperechoic
focus with a well-defined shadow, (2) hyperechoic focus
with a faint shadow and (3) hyperechoic focus with no
shadow. Doppler examination during the nodular or cystic
phase shows increased vascularity around the deposits [34],
which correlates well with the histopathological findings of
Uhthoff et al. [35], who showed how, during the reab-
sorption phase, the deposits are surrounded by phagocytes
and there was concomitant proliferation of vascular chan-
nels around the deposits.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is an additional but not
essential imaging tool, because it does not give any addi-
tional information in most cases [36, 37]. Calcific deposits
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have low signal intensity in all MRI sequences, although
areas of increased signal intensity can be found around
deposits in T2 images, signifying oedema around the
deposits in the resorptive phase. Such areas of increased
signal intensity can be misinterpreted as a RC lesion [38,
39]. The accuracy of MRI in identifying calcific deposits is
around 95 %, but it is more useful in cases of chronic CT,
which may be associated with RC tears, AC and TO [10,
38, 40, 41] (Fig 2). All these investigations and a thorough
clinical examination are of critical importance, especially
when the primary disease is associated with signs and
symptoms of other conditions, e.g., the stiffness occurring
in the acute stage of the disease, which should be differ-
entiated from that occurring in AC or secondary stiffness
occurring in RC tears. Imaging must be used to differen-
tiate chronic forms associated with TO from that occurring
in association with dystrophic calcification or in tumours
[42].
Treatment options
Conservative management is always the first line of treat-
ment. This includes non-steroidal anti-inflammatory drugs
(NSAIDs), physiotherapy, UGN and ESWT. The outcome
Fig. 1 A case with acute calcifying tendinitis of the rotator cuff.
(a) X-ray shows a large calcium deposit ([1.5 cm) at the insertion of
the supraspinatus tendon in touch with the greater tuberosity;
(b) ultrasound image in the same patient as a demonstrates a large
fragmented and punctate calcification (dotted line) with hypoechoic
area indicating oedema associated with the reabsorptive phase (white
arrows); (c) ultrasound-guided needling and lavage in the same case
as a and b with an abundant leakage of calcium (the window on the
left shows the calcium aspirated in a syringe)
Table 1 Radiographic classification of calcifying tendinitis of the
shoulder
Author Subtype Description
Bosworth [1] Small \0.5 cm
Medium 0.5–1.5 cm
Large 1.5 cm
DePalma et al. [7] Type I Fluffy, amorphous and ill
defined
Type II Defined and homogeneous
Mole` et al. (French
Arthroscopy Association)
[27]
Type A Dense, rounded, sharply
delineated
Type B Multilobular, radiodense,
sharp
Type C Radiolucent,
heterogeneous, irregular
outline
Type D Dystrophic calcific
deposit
Gartner et al. [28, 29] Type I Well demarcated, dense
Type II Soft contour/dense or
sharp/transparent
Type III Soft contour/translucent
and cloudy
Table 2 Percentage of rotator
cuff tendon involvement in cal-
cifying tendinitis of the shoulder
Tendon Percentage (%)
Supraspinatus 51
Infraspinatus 44.5
Teres minor 23.3
Subscapularis 3
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of conservative treatment was principally studied by Ogon
et al. [43], who described prognostic factors whose iden-
tification was helpful for tailoring treatment for favourable
outcome in the shortest possible time. They defined failure
of nonoperative therapy as persistence of symptomatic
calcific tendinitis of the shoulder after a minimum of
6 months of nonoperative treatment, including a minimum
of 3 months of standardised nonoperative treatment. They
concluded that the prognostic factors that significantly
increased the probability of failure of nonoperative therapy
(negative prognostic factors) were bilateral calcific deposit
occurrence, localization near the anterior portion of the
acromion, medial (subacromial) extension and high volume
of calcific deposit. Prognostic factors that significantly
reduced the probability of failure of nonoperative therapy
(positive prognostic factors) were Gartner type III calcific
deposit and lack of sonographic sound extinction of the
calcific deposit. Treatment can be modulated depending
upon the presence of these prognostic factors. Usually, the
acute phase requires NSAIDs to relieve the pain and
appropriate physiotherapy [passive range-of-motion
(ROM) exercises] to avoid stiffness of the shoulder. Local
steroid injection in the acute phase is a debatable topic, as
studies have shown it to have positive [35] or no effect
[44], or even a negative effect in the form of stopping
reabsorption of the deposits [45]. In most cases, conser-
vative treatment is sufficient for resolution of symptoms.
Cho et al. [46] reported excellent to good results in 72 % of
their patients.
Ultrasound-guided needling
Although UGN was first demonstrated under fluoroscopy
control by Comfort et al. [47], it was Farin et al. [33] who
described use of US for bursal lavage and needling. Since
then, it has been a commonly used intervention, as it is
inexpensive and can be carried out on an out-patient basis
under local anaesthesia (Fig. 1c). Gonzalez et al. [48]
recently published a study of 121 patients with 2-year
follow-up, reporting satisfactory results after UGN at
3 months. de Witte et al. [49] carried out a randomised
controlled trial (RCT) between UGN with subacromial
injection and subacromial injection alone; both groups
showed improvement, but the UGN group fared better as
compared with injection alone. A recent systemic review of
literature [50] for the efficacy of UGN in CT concluded
that, due to the variation in studies and the low quality of
evidence, the efficacy of UGN could not be firmly estab-
lished and additional high-quality studies are required.
Extracorporeal shock wave therapy
ESWT has been used for medical treatment since the
1990s. Its use for CT is increasing, and like UGN, there is a
lot of disparity, regarding the dosage (energy flux density),
duration (impulses) and interval of administration of
ESWT.
Low-energy (below 0.08 mJ/mm2), medium-energy
(0.08–0.28 mJ/mm2) and high-energy (0.28–0.60 mJ/mm2)
shock waves have been defined [51]. The shock waves can
be generated through electrohydraulic, electromagnetic or
piezoelectric mechanisms. Farr et al. [52] compared one
dose of 0.3 mJ/mm2 versus two doses of 0.2 mJ/mm2,
finding the former to be more effective. Ioppolo et al. [53]
also published a RCT and found 0.20 mJ/mm2 dosage to be
more effective than 0.10 mJ/mm2. Albert et al. [54] also
found in favour of high-dose therapy, though their follow-
up was only 3 months and they did not find any significant
differences in the size of deposits on X-ray examination.
Various energy doses of ESWT have been reported for
treatment of CT; most authors described good clinical
outcomes with low- and medium-energy waves [51–53,
55–57]. The authors of a RCT [55] in which the control
group was given sham treatment opined that the results
were better in the ESWT group. The researchers also
suggested other forms of treatment for patients who did not
respond to ESWT after 6 months. Krasny et al. [56]
compared ESWT alone and ESWT combined with UGN,
finding that the combined treatment was more effective in
relieving symptoms and that fewer patients in the com-
bined treatment group required surgery. Daecke et al. [57]
published long-term follow-up of patients managed with
ESWT; although 20 % of all patients required surgery,
70 % of patients were treated successfully and no long-
term complications were seen. Lee et al. [58] carried out a
systematic review to determine the midterm effectiveness
of ESWT, but due to the variability of treatment and reli-
ability of the available studies, they were not able to come
Fig. 2 Coronal fatty suppressed MRI reveals a focus of chronic
calcification with associated full-thickness supraspinatus tendon tear
(white arrows)
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to a conclusion regarding a particular dosage of treatment.
Kim et al. [59] carried out a comparative study between
UGN and ESWT, finding better radiological and clinical
outcomes in the UGN group, though both groups showed
improvement relative to initial findings.
Surgical treatment
After failure of conservative treatment modalities, surgical
removal of the deposits is the remaining option. Although
favourable results have been described with open removal
of calcific deposits [4, 60–62], arthroscopy has become the
preferred technique to treat the chronic formative phase of
CT, offering results similar to open surgery but with less
morbidity of the deltoid [63–69] (Fig. 3a, b). However,
many issues remain under debate, such as repairing versus
leaving the defect created, complete versus incomplete
removal of the deposits and removal of deposits versus
only acromioplasty. Ark et al. [64] published a report of 23
patients suggesting that complete removal of the deposits is
not essential; they also did not attempt repair of the defects
created following the removal of deposits. Other
researchers [65, 66] have also made similar suggestions. In
their study, Jerosch et al. [67] concluded that repair is not
required following removal of the deposits, but they
insisted on complete removal of the deposits. In contrast,
Porcellini et al. [68] recommended complete removal of
deposits followed by repair of the defect in the tendon,
using simple side-to-side sutures or suture anchors
depending upon the size of the residual defect. They argued
that repair gives similar results without the fear of propa-
gation of the tear and also helps in early patient rehabili-
tation. Tillander et al. [69] compared the outcome of
acromioplasty in 50 patients: 25 with CT and another 25
with other causes of impingement syndrome. They did not
find any significant difference between the Constant scores
of the two groups at 2 years and recommended that the
deposits should be left alone. However, other authors [64–
68] recommended acromioplasty only in cases of visible
mechanical impingement during arthroscopy, characterised
by roughening of the ligament and osteophytes on the
undersurface of the ligaments, as it did not have any
additional benefit and the number of cases requiring
acromioplasty varied in each of the studies.
Most authors [64–66, 68] recommended informing the
patient about delayed recovery post-surgery and were of
the opinion that surgical treatment should be reserved for
patients not responding to conservative treatment for more
than 6 months.
Complications
In a recent review, Merolla et al. [11] described various
complications associated with CT. They categorised pain
as a complication, as the majority of patients with CT are
asymptomatic. Other complications in their study were
secondary AC and RC tears, both of which could occur
during the primary disease or post-surgical intervention.
They also pointed out ossifying tendinitis, which is an
extremely rare condition occurring following surgical
removal of calcium deposits. Many authors [10, 11, 38, 40,
41] have described TO of the greater tuberosity as an
occurrence along with CT of the RC. Porcellini et al. [10]
suggested that TO should be identified as a different form
of CT which is prone to delayed recovery of patients
managed conservatively and surgically. During UGN, mild
vasovagal syncope may occur. High-dose ESWT is asso-
ciated with pain sometimes requiring local anaesthesia, and
local haematoma, erythema and ecchymosis have also been
reported. Osteonecrosis of the humeral head has also been
described [70].
Fig. 3 (a) Arthroscopic findings shows a complete insertional
supraspinatus tendon tear after complete removal of a calcium
deposit; (b) supraspinatus tendon-to-bone repair with a double suture
anchor at the end of the arthroscopic procedure
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Overview
CT of the RC is a controversial topic with several treatment
options that depend on the biologic stage of the disease.
Although reabsorption occurs spontaneously in the major-
ity of cases, a subpopulation of patients with persistent
painful shoulder require conservative or operative man-
agement. In addition, some complications such as TO, AC
or ossifying tendinitis (very rare) may give rise to pro-
longed pain resistant to common conservative therapies.
UGN is indicated in the acute phase, but good results have
also been found in patients with chronic calcific deposits.
ESWT can be reasonably used in chronic calcific cases,
even in combination with UGN. Surgical treatment should
be considered when conservative measures have failed or
in cases with US or MRI evidence of RC tears.
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